Trade Summary

4 days ago, Sabag Mark, serving as See "Remarks" at Teva Pharmaceutical Industries Ltd (TEVA), sold 144,180 shares at $34.99 per share, for a total transaction value of $5,045,118.00. Following this transaction, Sabag Mark now holds 80,760 shares of TEVA.

This sale represents a 64.00% decrease in Sabag Mark's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 1, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 4, 2026, 3 days after the trade was made.

Teva Pharmaceutical Industries Ltd operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.